Tag: Medicine
-
Combination Immunotherapy Shows No Additional Benefit for Most Advanced Cancers
A combination immunotherapy treatment of nivolumab plus ipilimumab was associated with no improvement in survival for advanced cancers other than melanoma, when compared to nivolumab alone, according to a recent Northwestern Medicine meta-analysis published in JAMA Oncology.
-
First Device to Monitor Transplanted Organs, Detect Early Signs of Rejection
Northwestern University investigators have developed the first electronic device for continuously monitoring the health of transplanted organs in real time.
-
Study Discovers Novel Therapeutic Target for Acute Respiratory Distress Syndrome
A new Northwestern Medicine study has discovered a novel therapeutic target and therapeutic agents for older patients with acute respiratory distress syndrome, according to recent findings published in Science Translational Medicine.
-
Chandel Receives 2023 Lurie Prize in Biomedical Sciences
Navdeep Chandel, PhD, the David W. Cugell, MD, Professor of Medicine in the Division of Pulmonary and Critical Care and of Biochemistry and Molecular Genetics, has been named a recipient of the 2023 Lurie Prize in Biomedical Sciences by the Foundation for the National Institutes of Health.
-
New Cancer Drug May Also Curb Peanut Allergies
A new drug used to treat cancer may also prevent allergic reactions to peanuts, according to a study published in the Journal of Clinical Investigation.
-
Mitochondria Regulate Cellular Signaling for Proper Lung Development
Northwestern Medicine investigators have discovered that mitochondria regulate essential cellular signaling for the development of epithelial cells in the lungs, cells which are crucial for the exchange of oxygen and carbon dioxide to avoid respiratory failure, according to findings published in Nature.
-
McDermott Honored With AHA Clinical Research Prize
Mary McDermott, MD, ’92 GME, the Jeremiah Stamler Professor of Medicine in the Division of General Internal Medicine, has been awarded the American Heart Association 2023 Clinical Research Prize.
-
Metformin May Prevent Long COVID, Trial Finds
Metformin, a drug commonly used to treat diabetes, may prevent the development of “long COVID,” according to a clinical trial published in The Lancet Infectious Diseases.
-
Using Physiology to Predict Treatment Response in Eosinophilic Esophagitis
Northwestern Medicine scientists have identified and characterized common symptoms and patterns in Eosinophilic esophagitis, according to a study published in the journal Gastroenterology, findings that will help predict how patients will respond to treatment.
-
Checkpoint Inhibitor Plus Chemotherapy Improves Outcomes for Hodgkin Lymphoma
Adding a checkpoint inhibitor to conventional chemotherapy improved outcomes for patients with relapsed or refractory classic Hodgkin lymphoma, according to a Northwestern Medicine phase II clinical trial published in JAMA Oncology.
